Clinical trial
SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.
NCT01295151
Study timeline
Study start (unknown)2011-08-01Date precision: month
Registry last updated2016-11-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rheumatoid Arthritisunresolved
Interventions
EtanerceptDRUG · verified · RxNorm: etanercept
AbataceptDRUG · verified · RxNorm: abatacept
RituximabBIOLOGICAL
AdalimumabDRUG · verified · RxNorm: adalimumab
Certolizumab PegolDRUG · verified · RxNorm: certolizumab pegol
InfliximabDRUG · verified · RxNorm: infliximab
GolimumabDRUG · verified · RxNorm: golimumab
Sponsors & collaborators
Julia Brownlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01295151 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.